Recent research has shown that PCSK9 not only regulates LDL-C concentration but also facilitates platelet activation and coagulation, and increase Inflammation, OS, and endothelial dysfunction (20, 23), that increase risk of MI incidence. The gene discussed is PCSK9; the disease is myocardial infarction.